Your browser doesn't support javascript.
A Multitrait Locus Regulates Sarbecovirus Pathogenesis.
Schäfer, Alexandra; Leist, Sarah R; Gralinski, Lisa E; Martinez, David R; Winkler, Emma S; Okuda, Kenichi; Hawkins, Padraig E; Gully, Kendra L; Graham, Rachel L; Scobey, D Trevor; Bell, Timothy A; Hock, Pablo; Shaw, Ginger D; Loome, Jennifer F; Madden, Emily A; Anderson, Elizabeth; Baxter, Victoria K; Taft-Benz, Sharon A; Zweigart, Mark R; May, Samantha R; Dong, Stephanie; Clark, Matthew; Miller, Darla R; Lynch, Rachel M; Heise, Mark T; Tisch, Roland; Boucher, Richard C; Pardo Manuel de Villena, Fernando; Montgomery, Stephanie A; Diamond, Michael S; Ferris, Martin T; Baric, Ralph S.
  • Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Leist SR; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Gralinski LE; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Martinez DR; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Winkler ES; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Okuda K; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Hawkins PE; Marsico Lung Institute, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Gully KL; Marsico Lung Institute, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Graham RL; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Scobey DT; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Bell TA; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Hock P; Department of Genetics, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Shaw GD; Department of Genetics, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Loome JF; Department of Genetics, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Madden EA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Anderson E; Department of Microbiology and Immunology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Baxter VK; Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina, Chapel Hill North Carolina, USA.
  • Taft-Benz SA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Zweigart MR; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • May SR; Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina, Chapel Hill North Carolina, USA.
  • Dong S; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Clark M; Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina, Chapel Hill North Carolina, USA.
  • Miller DR; Department of Genetics, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Lynch RM; Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina, Chapel Hill North Carolina, USA.
  • Heise MT; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Tisch R; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Boucher RC; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Pardo Manuel de Villena F; Department of Microbiology and Immunology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Montgomery SA; Department of Genetics, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Diamond MS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Ferris MT; Department of Genetics, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Baric RS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
mBio ; 13(4): e0145422, 2022 08 30.
Article in English | MEDLINE | ID: covidwho-1950003
ABSTRACT
Infectious diseases have shaped the human population genetic structure, and genetic variation influences the susceptibility to many viral diseases. However, a variety of challenges have made the implementation of traditional human Genome-wide Association Studies (GWAS) approaches to study these infectious outcomes challenging. In contrast, mouse models of infectious diseases provide an experimental control and precision, which facilitates analyses and mechanistic studies of the role of genetic variation on infection. Here we use a genetic mapping cross between two distinct Collaborative Cross mouse strains with respect to severe acute respiratory syndrome coronavirus (SARS-CoV) disease outcomes. We find several loci control differential disease outcome for a variety of traits in the context of SARS-CoV infection. Importantly, we identify a locus on mouse chromosome 9 that shows conserved synteny with a human GWAS locus for SARS-CoV-2 severe disease. We follow-up and confirm a role for this locus, and identify two candidate genes, CCR9 and CXCR6, that both play a key role in regulating the severity of SARS-CoV, SARS-CoV-2, and a distantly related bat sarbecovirus disease outcomes. As such we provide a template for using experimental mouse crosses to identify and characterize multitrait loci that regulate pathogenic infectious outcomes across species. IMPORTANCE Host genetic variation is an important determinant that predicts disease outcomes following infection. In the setting of highly pathogenic coronavirus infections genetic determinants underlying host susceptibility and mortality remain unclear. To elucidate the role of host genetic variation on sarbecovirus pathogenesis and disease outcomes, we utilized the Collaborative Cross (CC) mouse genetic reference population as a model to identify susceptibility alleles to SARS-CoV and SARS-CoV-2 infections. Our findings reveal that a multitrait loci found in chromosome 9 is an important regulator of sarbecovirus pathogenesis in mice. Within this locus, we identified and validated CCR9 and CXCR6 as important regulators of host disease outcomes. Specifically, both CCR9 and CXCR6 are protective against severe SARS-CoV, SARS-CoV-2, and SARS-related HKU3 virus disease in mice. This chromosome 9 multitrait locus may be important to help identify genes that regulate coronavirus disease outcomes in humans.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / Communicable Diseases / Severe acute respiratory syndrome-related coronavirus / COVID-19 Type of study: Cohort study / Prognostic study / Randomized controlled trials Limits: Animals / Humans Language: English Journal: MBio Year: 2022 Document Type: Article Affiliation country: Mbio.01454-22

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / Communicable Diseases / Severe acute respiratory syndrome-related coronavirus / COVID-19 Type of study: Cohort study / Prognostic study / Randomized controlled trials Limits: Animals / Humans Language: English Journal: MBio Year: 2022 Document Type: Article Affiliation country: Mbio.01454-22